# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001493152-24-046325
Filing Date
2024-11-15
Accepted
2024-11-15 16:59:47
Documents
6

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 |  | formdefa14-a.htm | DEFA14A | 36313
2 |  | formdefa14-a_001.jpg | GRAPHIC | 724821
3 |  | formdefa14-a_002.jpg | GRAPHIC | 488026
4 |  | formdefa14-a_003.jpg | GRAPHIC | 733907
5 |  | formdefa14-a_005.jpg | GRAPHIC | 249670
6 |  | formdefa14-a_006.jpg | GRAPHIC | 211445
| Complete submission text file | 0001493152-24-046325.txt |  | 3354194

Mailing Address 2117 SW HIGHWAY 484 OCALA FL 32801
Business Address 2117 SW HIGHWAY 484 OCALA FL 32801 352-448-7797
AIM ImmunoTech Inc. (Filer) CIK: 0000946644 (see all company filings)

EIN.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-27072 | Film No.: 241468697
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)